Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)

BME:ROVI Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	27.19	25.32	124.95	99.04	53.16
Short-Term Investments	0.83	0.11	0.09	0.1	0.07
Cash & Short-Term Investments	28.02	25.44	125.03	99.14	53.23
Cash Growth	10.15%	-79.66%	26.13%	86.22%	-21.14%
Accounts Receivable	114.83	124.55	160.23	129.8	63.34
Other Receivables	12.61	15.91	21.06	27.83	18.61
Receivables	127.44	140.46	181.28	157.63	81.95
Inventory	329.95	337.97	311.94	245.47	227.2
Prepaid Expenses	2.69	2.73	2.03	1.79	0.01
Other Current Assets	1.51	2.74	2.79	2.33	2.18
Total Current Assets	489.61	509.33	623.07	506.36	364.58
Property, Plant & Equipment	286.62	253.65	215.54	181.78	155.4
Long-Term Investments	19.52	0.59	2.2	2.07	1.88
Other Intangible Assets	28.23	27.74	29.14	31.51	33.93
Long-Term Deferred Tax Assets	2.26	2.34	2.08	3.85	11.11
Long-Term Deferred Charges	5.72	6.16	6.6	7.05	7.49
Other Long-Term Assets	0.07	0.07	0.07	0.07	0.07
Total Assets	832.02	799.88	878.7	732.68	574.44
Accounts Payable	89.93	109.89	125.87	99.4	65.19
Accrued Expenses	33.19	28.83	31.67	24.6	23.85
Current Portion of Long-Term Debt	17.84	8.06	8.27	2.98	2.95
Current Portion of Leases	5.85	5.13	4.46	3.44	3.07
Current Income Taxes Payable	2.38	5.26	-	0.68	-
Current Unearned Revenue	5.25	39.51	115.39	58.12	25.5
Other Current Liabilities	2.21	3.17	8.23	1.17	2.33
Total Current Liabilities	156.65	199.84	293.89	190.39	122.89
Long-Term Debt	80.5	38.58	46.04	52.52	53.94
Long-Term Leases	10.22	13.67	13.4	14.22	14.48
Long-Term Unearned Revenue	2.75	2.79	3.32	3.79	8.5
Long-Term Deferred Tax Liabilities	0.37	1.52	0.68	0.78	0.93
Total Liabilities	250.48	256.39	357.32	261.7	200.74
Common Stock	3.07	3.24	3.24	3.36	3.36
Additional Paid-In Capital	87.64	87.64	87.64	87.64	87.64
Retained Earnings	486.89	556.21	456.7	446.1	302.89
Treasury Stock	-5.55	-107.68	-27.56	-66.12	-20.19
Comprehensive Income & Other	-0.02	-0.02	-0.01	-0	-0
Total Common Equity	572.03	539.39	520.01	470.98	373.7
Minority Interest	9.51	4.11	1.37	-	-
Shareholders' Equity	581.54	543.49	521.38	470.98	373.7
Total Liabilities & Equity	832.02	799.88	878.7	732.68	574.44
Total Debt	114.41	65.43	72.17	73.16	74.44
Net Cash (Debt)	-86.39	-39.99	52.87	25.97	-21.21
Net Cash Growth	-	-	103.55%	-	-
Net Cash Per Share	-1.69	-0.75	0.99	0.47	-0.38
Filing Date Shares Outstanding	51.15	51.82	53.37	54.85	55.4
Total Common Shares Outstanding	51.15	51.82	53.37	54.85	55.4
Working Capital	332.96	309.49	329.19	315.97	241.69
Book Value Per Share	11.18	10.41	9.74	8.59	6.75
Tangible Book Value	543.8	511.65	490.87	439.46	339.77
Tangible Book Value Per Share	10.63	9.87	9.20	8.01	6.13
Land	74.8	60.65	45.12	37.25	35.75
Machinery	404.19	372.97	303.78	275.44	250.22
Construction In Progress	11.01	8.47	40.17	28.06	14.68

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.